• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型神经纤维瘤病患者的胰腺囊性神经内分泌肿瘤

Cystic Pancreatic Neuroendocrine Tumor in a Patient with Neurofibromatosis Type 1.

作者信息

Shinozaki Hiroharu, Sasakura Yuuichi, Shinozaki Satoshi, Terauchi Toshiaki, Matsui Junichi, Kobayashi Kenji, Lefor Alan Kawarai, Ogata Yoshiro

机构信息

Department of Surgery, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan.

Shinozaki Medical Clinic, Utsunomiya, Japan.

出版信息

Case Rep Gastroenterol. 2021 Feb 1;15(1):108-114. doi: 10.1159/000510210. eCollection 2021 Jan-Apr.

DOI:10.1159/000510210
PMID:33708057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7923728/
Abstract

Neurofibromatosis type 1 (NF-1) is strongly associated with neurofibromas and malignancies. Solid pancreatic neuroendocrine tumors (PanNETs) have been recently reported in patients with NF-1. PanNETs are always solid and rarely present with a cystic appearance due to central necrosis and hemorrhage caused by rapid growth. A 33-year-old female diagnosed with NF-1 at age 16 was referred for evaluation of a pelvic mass found on abdominal ultrasound. Magnetic resonance imaging showed a 6 cm solid pelvic mass adjacent to the left external iliac artery, and contrast-enhanced computed tomography scan showed a 3-cm solid para-aortic mass and a 3-cm cystic mass in the pancreatic tail. Endoscopic ultrasonography showed a cystic tumor with necrotic tissue and septa. Preoperative diagnosis was pancreatic cystic malignancy with para-aortic lymph node metastasis accompanied with a pelvic neurofibroma. These lesions were resected simultaneously. The specimen resected from the pancreas showed a necrotizing cystic tumor invading abutting lymph nodes. Immunohistochemical analysis showed positive chromogranin A and synaptophysin. The Ki-67 index was <1%, and the mitotic count was 1/10 in high power field. Therefore, a non-functional PanNET (grade G1) was diagnosed. The pelvic and para-aortic tumors were both neurofibromas. A cystic appearance is atypical for PanNET and makes preoperative diagnosis difficult. To the best of our knowledge, this is the first report of a cystic PanNET in a patient with NF-1.

摘要

1型神经纤维瘤病(NF-1)与神经纤维瘤和恶性肿瘤密切相关。最近有报道称NF-1患者出现实性胰腺神经内分泌肿瘤(PanNETs)。PanNETs通常为实性,由于快速生长导致的中央坏死和出血,很少呈现囊性外观。一名16岁时被诊断为NF-1的33岁女性因腹部超声发现盆腔肿块而前来评估。磁共振成像显示左髂外动脉旁有一个6厘米的实性盆腔肿块,增强计算机断层扫描显示胰腺尾部有一个3厘米的实性腹主动脉旁肿块和一个3厘米的囊性肿块。内镜超声显示一个有坏死组织和间隔的囊性肿瘤。术前诊断为胰腺囊性恶性肿瘤伴腹主动脉旁淋巴结转移及盆腔神经纤维瘤。这些病变同时被切除。从胰腺切除的标本显示为一个坏死性囊性肿瘤,侵犯了相邻的淋巴结。免疫组织化学分析显示嗜铬粒蛋白A和突触素呈阳性。Ki-67指数<1%,高倍视野下有丝分裂计数为1/10。因此,诊断为无功能PanNET(G1级)。盆腔和腹主动脉旁肿瘤均为神经纤维瘤。PanNET出现囊性外观不典型,术前诊断困难。据我们所知,这是首例NF-1患者出现囊性PanNET的报道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/c726abdc121c/crg-0015-0108-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/030b2ef0f6d6/crg-0015-0108-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/10282ff26ae8/crg-0015-0108-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/fbd690bed89c/crg-0015-0108-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/c726abdc121c/crg-0015-0108-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/030b2ef0f6d6/crg-0015-0108-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/10282ff26ae8/crg-0015-0108-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/fbd690bed89c/crg-0015-0108-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f983/7923728/c726abdc121c/crg-0015-0108-g04.jpg

相似文献

1
Cystic Pancreatic Neuroendocrine Tumor in a Patient with Neurofibromatosis Type 1.1型神经纤维瘤病患者的胰腺囊性神经内分泌肿瘤
Case Rep Gastroenterol. 2021 Feb 1;15(1):108-114. doi: 10.1159/000510210. eCollection 2021 Jan-Apr.
2
Cystic pancreatic neuroendocrine tumors: a clinicopathologic study.胰腺囊性神经内分泌肿瘤:临床病理研究。
Am J Surg Pathol. 2012 Nov;36(11):1666-73. doi: 10.1097/PAS.0b013e31826a0048.
3
Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors.扩散加权磁共振成像在预测G1/G2级胰腺神经内分泌肿瘤世界卫生组织分级中的价值
Oncol Lett. 2017 Jun;13(6):4141-4146. doi: 10.3892/ol.2017.6029. Epub 2017 Apr 11.
4
Neuroendocrine neoplasm of pancreas with cystic degeneration mimicking mucinous cystic neoplasm.胰腺神经内分泌肿瘤伴囊性变,酷似黏液性囊性肿瘤。
Clin J Gastroenterol. 2018 Aug;11(4):333-337. doi: 10.1007/s12328-018-0846-4. Epub 2018 Mar 13.
5
Pancreatic neuroendocrine tumor with complete replacement of the pancreas by serous cystic neoplasms in a patient with von Hippel-Lindau disease: a case report.冯·希佩尔-林道病患者胰腺神经内分泌肿瘤被浆液性囊性肿瘤完全取代:一例报告
Surg Case Rep. 2017 Sep 25;3(1):105. doi: 10.1186/s40792-017-0381-4.
6
The rare case of a cystic pancreatic neuroendocrine tumor.一例罕见的胰腺囊性神经内分泌肿瘤病例。
Autops Case Rep. 2020 Jun 5;10(3):e2020171. doi: 10.4322/acr.2020.171.
7
Malignant peripheral nerve sheath tumor of the pancreas-A case report.胰腺恶性周围神经鞘瘤——一例报告
Int J Surg Case Rep. 2019;55:239-242. doi: 10.1016/j.ijscr.2019.02.011. Epub 2019 Feb 13.
8
Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).无功能性胰腺神经内分泌肿瘤(NF-PanNETs)中淋巴结受累的模式和临床预测因素。
JAMA Surg. 2013 Oct;148(10):932-9. doi: 10.1001/jamasurg.2013.3376.
9
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation.儿童胰腺神经内分泌肿瘤伴结节性硬化症 2 型(TSC2)突变。
Endocr Pract. 2013 Sep-Oct;19(5):e124-8. doi: 10.4158/EP13010.CR.
10
A case of mucinous cystic neoplasm of the pancreas misdiagnosed as a pancreatic pseudocyst at the initial exam and resected after a 2-year follow-up.一例胰腺黏液性囊性肿瘤在初次检查时被误诊为胰腺假性囊肿,经过2年随访后接受了手术切除。
J Med Ultrason (2001). 2015 Apr;42(2):257-65. doi: 10.1007/s10396-014-0581-5. Epub 2014 Oct 8.

引用本文的文献

1
Pediatric Neuroendocrine Neoplasms: Rare Malignancies with Incredible Variability.小儿神经内分泌肿瘤:具有惊人变异性的罕见恶性肿瘤。
Cancers (Basel). 2022 Oct 15;14(20):5049. doi: 10.3390/cancers14205049.

本文引用的文献

1
Cystic pancreatic neuroendocrine tumours - a gastroenterologist's point of view.囊性胰腺神经内分泌肿瘤——胃肠病学家的观点
Endokrynol Pol. 2018;69(3):320-325. doi: 10.5603/EP.2018.0034.
2
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.国际共识修订版福冈胰腺导管内乳头状黏液瘤管理指南。
Pancreatology. 2017 Sep-Oct;17(5):738-753. doi: 10.1016/j.pan.2017.07.007. Epub 2017 Jul 13.
3
Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.胰腺神经内分泌肿瘤:囊性成分的程度可预测预后。
Surgery. 2016 Sep;160(3):708-13. doi: 10.1016/j.surg.2016.04.005. Epub 2016 May 20.
4
Neurofibromatosis type 1: a multidisciplinary approach to care.神经纤维瘤病 1 型:多学科护理方法。
Lancet Neurol. 2014 Aug;13(8):834-43. doi: 10.1016/S1474-4422(14)70063-8.
5
Cystic pancreatic neuroendocrine tumors: the value of cytology in preoperative diagnosis.胰腺囊性神经内分泌肿瘤:细胞学检查在术前诊断中的价值。
Cancer Cytopathol. 2014 Jun;122(6):435-44. doi: 10.1002/cncy.21403. Epub 2014 Mar 3.
6
Neurofibromatosis Type 1 and pancreatic islet cell tumours: an association which should be recognized.1型神经纤维瘤病与胰岛细胞瘤:一种应被认识到的关联。
QJM. 2015 Jul;108(7):573-6. doi: 10.1093/qjmed/hcs203. Epub 2012 Nov 19.
7
A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1.1 型神经纤维瘤病患者胰腺神经内分泌肿瘤 1 例。
World J Surg Oncol. 2012 Jul 23;10:153. doi: 10.1186/1477-7819-10-153.
8
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.神经纤维瘤病 1 型与肿瘤发生:分子机制与治疗意义。
Neurosurg Focus. 2010 Jan;28(1):E8. doi: 10.3171/2009.11.FOCUS09221.
9
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.遗传性胰腺内分泌肿瘤综合征:分子发病机制、诊断、管理及争议方面的进展
Cancer. 2008 Oct 1;113(7 Suppl):1807-43. doi: 10.1002/cncr.23648.
10
Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.分子生物学对患有1型神经纤维瘤病的胃肠道间质瘤患者的治疗影响。
Clin Cancer Res. 2008 Jul 15;14(14):4550-5. doi: 10.1158/1078-0432.CCR-08-0086.